National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 312 cases where Vaccine is HPV4 and Symptom is Death

Case Details

This is page 13 out of 32

Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next


VAERS ID: 627312 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-03-16
Entered: 2016-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Arrhythmia, Death, Electrocardiogram QT prolonged, Long QT syndrome, Product label issue
SMQs:, Torsade de pointes/QT prolongation (narrow), Conduction defects (narrow), Torsade de pointes, shock-associated conditions (narrow), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Medication errors (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Electrocardiogram, long QT
CDC Split Type: WAES1603USA006278

Write-up: This spontaneous report was received from a pharmacist via a returned survey and refers to unspecified number of patients of unknown age and gender. There was no information about the patient''s concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with GARDASIL (dose, frequency, route of administration, lot # and expiration date were not reported). On unknown dates, the patients experienced arrhythmogenic events, arrhythmogenic deaths or long QT episodes. The reporter found out about those events from a Food and Drug Administration (FDA) document from 2010. Since the pharmacist had a patient with congenital Long QT syndrome and the patient''s family was unsure if GARDASIL was safe to give, the pharmacist wanted the same information for the most recent 6 years to make an educated assessment for the patient. The pharmacist complained that these serious events were not mentioned in the package insert, while that information was needed for the patient. The outcome of arrhythmogenic events and long QT episodes was unknown. The outcome of arrhythmogenic deaths was fatal. The reporter considered the events to be associated with GARDASIL. Additional information has been requested.


VAERS ID: 632678 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-04-22
Entered: 2016-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Death, Premature menopause
SMQs:, Fertility disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1604USA013248

Write-up: This spontaneous report was received from a physician via a company representative and refers to an unspecified number of patients of unknown age and gender. The patients'' concurrent conditions and medical history were not provided. The reporter read in an article online that, on unspecified dates, an unspecified number of patients were vaccinated with GARDASIL (lot number, expiry date, dose, route and anatomical site of injection were not reported). Concomitant therapies were not provided. The article reported that an unspecified number of patients developed premature ovarian failure an unspecified time after receiving GARDASIL. Additionally, the article mentioned that an unspecified number of patients passed away on unknown dates, on an unspecified time after receiving GARDASIL. It was unspecified if the patients that passed away were the same patients that developed premature ovarian failure. It was unknown if an autopsy was performed. At the time of reporting, the outcome of premature ovarian failure was unknown. The reporter did not provide a causality assessment between the reported events and the GARDASIL. The cause of death was not mentioned. Additional information is not expected, as the reporting physician did not allow further contact for follow-up.


VAERS ID: 634742 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-05-06
Entered: 2016-05-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1605USA003129

Write-up: This spontaneous report was received from a consumer referring to a young patient of unknown age and gender. The patient''s pertinent medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with GARDASIL (anatomical route of vaccination, lot number and expiration date were not provided). The patient''s concomitant medications were not reported. The reported stated, that after watching TV news, heard about a young child who collapsed and died after receiving GARDASIL. At the time of the report, the outcome was reported as fatal. Relatedness between the adverse event and vaccination with GARDASIL was not provided. This is one of several cases received from the same source. MARRS: 1605USA003026. Additional information has been requested.


VAERS ID: 636334 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2009-05-01
Submitted: 2016-05-20
   Days after onset:2576
Entered: 2016-05-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1605USA009589

Write-up: Information was received from a physician via an internet article regarding cases in litigation concerning female patients of unknown age, who received vaccinations with GARDASIL (lot numbers, dates of vaccination, dosages, and routes of administration not reported). It was reported that between May 2009 and September 2010, 16 deaths occurred after GARDASIL vaccination (causes of deaths not reported). It was unknown if autopsies were performed. Upon internal review, 16 deaths was determined to be medically significant. This is one of several reports from the same source. Additional information is not expected.


VAERS ID: 649444 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-26
Entered: 2016-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1606USA012148

Write-up: This spontaneous report was received from a physician via company representative, who saw an article by another physician. This report refers to 44 female patients of unknown age, whose concurrent conditions, medical history and concomitant medications were not known. On an unknown date, the patients were vaccinated with GARDASIL (details not known). As per the article the 44 patients died as a result of receiving GARDASIL and hence causality of death was considered to be related to the vaccine. The reporter considered the event serious (death). Upon internal review, death was considered to be medically significant. Additional information is not expected as the physician does not want to be contacted.


VAERS ID: 649671 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-29
Entered: 2016-08-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1608USA012926

Write-up: This spontaneous report was received from a physician via a company representative and refers to 44 female patients of unknown age. There was no information regarding the patients'' pertinent medical history, drug reactions, allergies or concomitant therapies provided. The physician found out about the event reported below from an online article. On unknown dates, the patients were vaccinated with doses of GARDASIL (lot #, expiration date, exact dose, site and route of administration were not reported). On unknown dates, the patients died as a result of receiving GARDASIL (also reported as they died from these vaccines). The relatedness between the event and GARDASIL was assessed as related. Upon internal review, the event of death was determined to be medically significant. This is one of two reports received from the same source. Additional information is not expected as there was no consent for follow-up.


VAERS ID: 650025 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-31
Entered: 2016-08-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1608USA013930

Write-up: This spontaneous report was received from a physician via a company representative and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients'' pertinent medical history, concomitant medication and drug reactions or allergies was reported. The physician reported that she reviewed an unspecified article that described the patients, who, on unknown dates, were vaccinated with doses of GARDASIL (strength, dose, route of administration, anatomical location, lot# and expiration date were not provided). On unknown dates, an unspecified amount of time after the doses were administered, the patients were diagnosed with Guillain-Barre Syndrome and there were 44 deaths associated with GARDASIL. The outcome of Guillain-Barre syndrome was reported as unknown. The reporter considered death to be related to GARDASIL. The relatedness between Guillain-Barre syndrome and GARDASIL was not reported. Upon internal review, the events of Guillain-Barre syndrome and death were considered to be medically significant. Additional information has been requested.


VAERS ID: 653657 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-15
Entered: 2016-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609USA006280

Write-up: Information has been received from a molecular biology student, who obtained the information from a Vaccine Adverse Event Reporting System (VAERS) report, concerning 235 patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with unspecified doses of GARDASIL (strength, dosage schedule, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant medications were not provided. On unknown dates, the patients died. The causes of death were unknown, and it was also unknown whether autopsies were performed. The reporter indicated that he read the deaths were related to GARDASIL and he was concerned about the number of deaths reported for GARDASIL products. Upon internal review, death was determined to be medically significant. Additional information has been requested.


VAERS ID: 655947 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-29
Entered: 2016-09-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609USA013034

Write-up: Information was received from a chief researcher through an online article via a company representative referring to 44 female patients of unknown age. The patients'' medical history, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with GARDASIL (lot#, expiration date, dose and route were unknown). On unknown dates, the patients died of this vaccine. The cause of death was unknown. It was unknown if autopsy was performed. The reporter considered death to be related to GARDASIL. Upon internal review, death was determined to be a medically significant event. This is one of several reports received from the same reporter. Additional information is not expected.


VAERS ID: 661043 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-10-24
Entered: 2016-10-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1610USA011804

Write-up: This spontaneous report was received from a physician via company representative concerning 200 patients of unknown age and gender. The physician reported that an unspecified article provided information regarding patients who on dates were vaccinated with GARDASIL and died an unspecified time after vaccination. There was no product quality complaint reported. The reporter did not provide the causality assessment for the events. the cause of death was not specified. Upon internal review death was considered to be medically significant. Additional information has been requested.


Result pages: prev   4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=13&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166